D.E. Shaw & Co’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.4K | Sell |
21,135
-4,205
| -17% | -$15.6K | ﹤0.01% | 2904 |
|
|
2025
Q1 | $81.8K | Sell |
25,340
-10,693
| -30% | -$34.5K | ﹤0.01% | 2858 |
|
|
2024
Q4 | $201K | Sell |
36,033
-3,117
| -8% | -$17.4K | ﹤0.01% | 2743 |
|
|
2024
Q3 | $423K | Sell |
39,150
-4,276
| -10% | -$46.2K | ﹤0.01% | 2548 |
|
|
2024
Q2 | $912K | Sell |
43,426
-322
| -0.7% | -$6.76K | ﹤0.01% | 2212 |
|
|
2024
Q1 | $1.39M | Buy |
+43,748
| New | +$1.39M | ﹤0.01% | 1954 |
|
|
2023
Q2 | – | Sell |
-81,457
| Closed | -$1.4M | – | 3172 |
|
|
2023
Q1 | $1.4M | Sell |
81,457
-107,932
| -57% | -$1.86M | ﹤0.01% | 2022 |
|
|
2022
Q4 | $4.21M | Buy |
189,389
+179,345
| +1,786% | +$3.98M | ﹤0.01% | 1559 |
|
|
2022
Q3 | $81K | Sell |
10,044
-15,626
| -61% | -$126K | ﹤0.01% | 3354 |
|
|
2022
Q2 | $179K | Buy |
+25,670
| New | +$179K | ﹤0.01% | 3421 |
|